Stablecoin Development Corporation · AMEX:SDEV
Stablecoin Development — NovaBay Pharmaceuticals — Life Science Investor Forum 2022
24 slides from Stablecoin Development's conference presentation, Sep 13, 2022

Slide 1: Corporate Update
Corporate Update September 2022 NYSE American: NBY

Slide 2: Forward-Looking Statements
Forward-Looking Statements This presentation contains forward-looking statements, within the meaning of applicable U.S. securities laws, which statements can, in some cases, be identified with terms such as “project,” “believe,” “may,” “plan,” “will,” “estimate,” “continue,” “anticipate,” “intend,”

Slide 3: Corporate Overview
Avenova for Eye Care Corporate Overview Established, High-Margin Brands • Avenova is the #1 antimicrobial lid & lash spray in the US dry eye market • DERMAdoctor acquisition (11/21) expanded portfolio in skincare market • PhaseOne cutting edge wound care technology DERMAdoctor Complementary Product

Slide 4: Investment Highlights
Investment Highlights Predictable, Recurring Revenue Multipronged Product Strategy Improving Operating Margin Well Capitalized Drive future success from current Accelerate topline growth from Leveraging DERMAdoctor’s Current financing expected to be Avenova and DERMAdoctor existing products with exp

Slide 5: Execution on Growth
Execution on Growth New Products Launches 01 DERMAdoctor Distribution Expansion 02 Domestic distribution expansion with Costco and QVC International distribution expansion in China (Tmall + UNQ) and European union Avenova Demographic Expansion 03 Avenova expanding into the eyelash extension market C

Slide 6: Introducing Our Executive Team
Introducing Our Executive Team Justin M. Hall, Esq. Andrew Jones Audrey Kunin, M.D. Chief Executive Officer Chief Financial Officer Chief Product Officer Justin Hall joined NovaBay in February 2013 and Andrew Jones joined NovaBay in May 2020 as Chief Financial Audrey Kunin, M.D. joined NovaBay in No

Slide 7: In the News
In the News NovaBay Pharmaceuticals NovaBay Pharmaceuticals’ NovaBay Pharmaceuticals Targets New Market with DERMAdoctor Products Now Reports Record Avenova Sales Antimicrobial Avenova Lid and Available at Target.com and During Amazon’s Prime Day Lash Spray for Lash Extensions Urbanoutfitters.com Ev

Slide 8: Avenova
AVENOVA’ purely yw.

Slide 9: Science for sore eyes.
Science for sore eyes. • No. 1 Doctor-Recommended Antimicrobial Lid & Lash Spray • Pioneering use of hypochlorous acid (HOCl) – a substance naturally produced by the body – for antimicrobial lid & lash spray • Kills a broad spectrum of bacteria and helps relieve chronic eye conditions like dry eye,

Slide 10: Avenova Efficacy Advantages
Avenova Efficacy Advantages Inferior formulation and packaging by competitors can result in an ineffective solution and may contain harmful impurities such as bleach, plastic leachables and detergents Lab Test Results for 3 Competitors Page 10

Slide 11: Avenova Sales Channels
Avenova Sales Channels Rx - Retail Pharmacy Physician Dispensed OTC • Physicians prescribe Avenova Rx • Physicians purchase Avenova Rx • Physicians refer patients to 40mL and patients fill 20mL, at a discounted price, and Avenova.com, Amazon, Walmart & prescriptions at a pharmacy of dispense the pro

Slide 12: Avenova Opportunities for Growth
Avenova Opportunities for Growth Rx + Retail Pharmacy • Partnership with ImprimisRx, the nations largest ophthalmic compounding pharmacy • Rx version of Avenova available at 99% of retail pharmacies nationwide Physician Dispensed • Promoted through targeted email sequencing campaigns • Using online

Slide 13: Rapid Uptake with Avenova DTC Strategy
Rapid Uptake with Avenova DTC Strategy Vast majority of unit sales are currently through OTC channel, less than 3 years from non-prescription product launch Broad product accessibility through major online retailers and in-store stocking at CVS Online “Subscribe & Save” feature on Avenova.com and Am

Slide 14: Complete Dry Eye Product Portfolio
Complete Dry Eye Product Portfolio One product for each step in the standard dry eye treatment regimen Drops + Compress + Cleanser + Wipes + Supplements Page 14

Slide 15: Addressing a New Demographic: Lash Extensions
Addressing a New Demographic: Lash Extensions Expansion into new, younger demographic for Avenova Creates cross-selling opportunities by demographic overlap with DERMAdoctor customers Ideal cleanser to make your long lashes last longer Lash extensions harbor extra bacteria increasing the risk of lid

Slide 16: DERMAdoctor
DERMAdoctor Skin. Caring. For all of you.

Slide 17: DERMAdoctor: Established Brand in Growing Skincare Market
DERMAdoctor: Established Brand in Growing Skincare Market Scientifically Formulated Significant Global Growth Established Brand Proprietary Products Opportunity • Founded in 1998 by Drs. • Created by board-certified • Cosmetic skincare products Audrey and Jeff Kunin dermatologist estimated to reach

Slide 18: Primary Product Families
Primary Product Families Kakadu C KP Duty AIN’T misbehavin’ Calm Cool + Corrected Vitamin C based elixirs Exfoliating body treatments targeting Suite of solutions for Created for irritable, itchy, challenged, with anti-aging properties Keratosis Pilaris to help alleviate dry, acne and related condit

Slide 19: DERMAdoctor Sales Channels
DERMAdoctor Sales Channels Direct DERMAdoctor.com Domestic Physician Offices International Current Int’l Distribution Expansion Opportunities • Middle East (Kuwait, UAE, Qatar, SA) • China • Great Britain • European Union • Central America • South America Page 19

Slide 20: Leveraging DERMAdoctor Brand
Leveraging DERMAdoctor Brand Awards and Recognition Dr. Kunin on TV Publications Page 20

Slide 21: New Partners Enhance Marketing in China
New Partners Enhance Marketing in China Major growth opportunity with new partners • Tmall store (Amazon equivalent) upgraded with Duomai • UNQ to provide additional influencer marketing Growing market for functional skincare products • China market expected to exceed $100 billion by 2024 • Accounti

Slide 22: Summary
N®vaBay SUMMARY Page 22

Slide 23: Financial and Operational Highlights
Avenova for Eye Care Financial and Operational Highlights Trailing twelve months net sales of $10.1 million • 18% year-over-year increase in OTC Avenova spray unit sales • DERMAdoctor expansion into Europe and China • Strong additional growth anticipated from DERMAdoctor brand in DERMAdoctor the sec

Slide 24: Investment Highlights
Investment Highlights Predictable, Recurring Revenue Multipronged Product Strategy Improving Operating Margin Well Capitalized Drive future success from current Accelerate topline growth from Leveraging DERMAdoctor’s Current financing expected to be Avenova and DERMAdoctor existing products with exp
Source: Internet Archive copy of novabay.com
More decks from Stablecoin Development Corporation
Investor Presentation (July 2024)18 slides · July 2024
Corporate Update (April 2024)22 slides · Apr 22, 2024
Merger or Acquisition (January 2022)20 slides · January 2022
Merger or Acquisition (September 2021)11 slides · Sep 29, 2021
H.C. Wainwright Global Investment Conference 202120 slides · September 2021
Investor Presentation (June 2021)19 slides · June 2021